Jaime Montero-Gonzalez

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Subcutaneous atezolizumab for the treatment of non-small cell lung cancer.

Subcutaneous atezolizumab for the treatment of non-small cell lung cancer.

Journal: Therapeutic delivery

Published: April 07, 2026

First-Line Treatment Strategies in IMDC Favourable-Risk Metastatic Clear Cell Renal Cell Carcinoma.

First-Line Treatment Strategies in IMDC Favourable-Risk Metastatic Clear Cell Renal Cell Carcinoma.

Journal: Oncology research

Published: December 15, 2025

Immunotherapy-Related Pancreatitis: A Case Series of 8 Patients from a High-Volume Oncology Centre.

Immunotherapy-Related Pancreatitis: A Case Series of 8 Patients from a High-Volume Oncology Centre.

Journal: Case reports in oncology

Published: June 09, 2025

Sidedness matters: Colon cancer outcomes in low-resource settings.

Sidedness matters: Colon cancer outcomes in low-resource settings.

Journal: World journal of clinical oncology

Published: April 27, 2025

Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment.

Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment.

Journal: International journal of molecular sciences

Published: January 01, 2025

Targeting HIF-2α: the role of belzutifan in clear cell renal carcinoma management.

Targeting HIF-2α: the role of belzutifan in clear cell renal carcinoma management.

Journal: Expert review of clinical pharmacology

Published: December 13, 2024

Current landscape in first-line treatment of metastatic hormone sensitive prostate cancer: a cost-effectiveness focused review.

Current landscape in first-line treatment of metastatic hormone sensitive prostate cancer: a cost-effectiveness focused review.

Journal: The oncologist

Published: November 19, 2024

Predictors of response to immunotherapy in colorectal cancer.

Predictors of response to immunotherapy in colorectal cancer.

Journal: The oncologist

Published: March 19, 2024

Considerations on the implementation of MAP4K4 inhibitors as cancer treatment.

Considerations on the implementation of MAP4K4 inhibitors as cancer treatment.

Journal: Expert opinion on therapeutic targets

Published: February 29, 2024

Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.

Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.

Journal: World journal of clinical oncology

Published: July 25, 2023

Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back.

Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back.

Journal: Molecules (Basel, Switzerland)

Published: April 08, 2022

Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer.

Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer.

Journal: World journal of gastrointestinal oncology

Published: March 19, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026